Literature DB >> 20676226

Improved Statistical Methods are Needed to Advance Personalized Medicine.

Farrokh Alemi1, Harold Erdman, Igor Griva, Charles H Evans.   

Abstract

Common methods of statistical analysis, e.g. Analysis of Variance and Discriminant Analysis, are not necessarily optimal in selecting therapy for an individual patient. These methods rely on group differences to identify markers for disease or successful interventions and ignore sub-group differences when the number of sub-groups is large. In these circumstances, they provide the same advice to an individual as the average patient. Personalized medicine needs new statistical methods that allow treatment efficacy to be tailored to a specific patient, based on a large number of patient characteristics. One such approach is the sequential k-nearest neighbor analysis (patients-like-me algorithm). In this approach, the k most similar patients are examined sequentially until a statistically significant conclusion about the efficacy of treatment for the patient-at-hand can be arrived at. For some patients, the algorithm stops before the entire set of data is examined and provides beneficial advice that may contradict recommendations made to the average patient. Many problems remain in creating statistical tools that can help individual patients but this is an important area in which progress in statistical thinking is helpful.

Entities:  

Year:  2009        PMID: 20676226      PMCID: PMC2911789          DOI: 10.2174/1876399500901010016

Source DB:  PubMed          Journal:  Open Transl Med J        ISSN: 1876-3995


  16 in total

Review 1.  Toward theragnostics.

Authors:  Frédéric Pene; Emilie Courtine; Alain Cariou; Jean-Paul Mira
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

2.  Bayesian Weibull tree models for survival analysis of clinico-genomic data.

Authors:  Jennifer Clarke; Mike West
Journal:  Stat Methodol       Date:  2008

3.  Differential weighting of common and distinctive components.

Authors:  I Ritov; I Gati; A Tversky
Journal:  J Exp Psychol Gen       Date:  1990-03

4.  Enrolling research subjects from clinical practice: ethical and procedural issues in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.

Authors:  Jonathan E Alpert; Melanie M Biggs; Lori Davis; Kathy Shores-Wilson; William R Harlan; Gregory W Schneider; Amy L Ford; Amy Farabaugh; Diane Stegman; A Louise Ritz; Mustafa M Husain; Laurie Macleod; Stephen R Wisniewski; A John Rush
Journal:  Psychiatry Res       Date:  2006-02-02       Impact factor: 3.222

Review 5.  Enabling personalized cancer medicine through analysis of gene-expression patterns.

Authors:  Laura J van't Veer; René Bernards
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

6.  Nanomedicine targets cancer.

Authors:  James R Heath; Mark E Davis; Leroy Hood
Journal:  Sci Am       Date:  2009-02       Impact factor: 2.142

7.  Identifying high-dimensional biomarkers for personalized medicine via variable importance ranking.

Authors:  Songjoon Baek; Hojin Moon; Hongshik Ahn; Ralph L Kodell; Chien-Ju Lin; James J Chen
Journal:  J Biopharm Stat       Date:  2008       Impact factor: 1.051

Review 8.  Warfarin dosing and the promise of pharmacogenomics.

Authors:  Todd E Dumas; Roy L Hawke; Craig R Lee
Journal:  Curr Clin Pharmacol       Date:  2007-01

Review 9.  Asthma genetics: personalizing medicine.

Authors:  Manoj R Warrier; Gurjit K Khurana Hershey
Journal:  J Asthma       Date:  2008-05       Impact factor: 2.515

Review 10.  Pharmacogenomic strategy for individualizing antidepressant therapy.

Authors:  Keh-Ming Lin; Roy H Perlis; Yu-Jui Yvonne Wan
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

View more
  7 in total

Review 1.  How New Technology Is Improving Physical Therapy.

Authors:  Johnny G Owens; Michelle R Rauzi; Andrew Kittelson; Jeremy Graber; Michael J Bade; Julia Johnson; Dustin Nabhan
Journal:  Curr Rev Musculoskelet Med       Date:  2020-04

Review 2.  Integrated Genomic Medicine: A Paradigm for Rare Diseases and Beyond.

Authors:  N J Schork; K Nazor
Journal:  Adv Genet       Date:  2017-07-25       Impact factor: 1.944

3.  Person-Centered Care and Physical Therapy: A "People-Like-Me" Approach.

Authors:  Andrew J Kittelson; Thomas J Hoogeboom; Margaret Schenkman; Jennifer E Stevens-Lapsley; Nico L U van Meeteren
Journal:  Phys Ther       Date:  2020-01-23

4.  YM500v3: a database for small RNA sequencing in human cancer research.

Authors:  I-Fang Chung; Shing-Jyh Chang; Chen-Yang Chen; Shu-Hsuan Liu; Chia-Yang Li; Chia-Hao Chan; Chuan-Chi Shih; Wei-Chung Cheng
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

5.  N-of-1 Design and Its Applications to Personalized Treatment Studies.

Authors:  Tailiang Xie; Zhuoxin Yu
Journal:  Stat Biosci       Date:  2016-09-06

6.  From small studies to precision medicine: prioritizing candidate biomarkers.

Authors:  Daniel P Gaile; Jeffrey C Miecznikowski
Journal:  Genome Med       Date:  2013-11-29       Impact factor: 11.117

7.  Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder.

Authors:  Hoda Shirafkan; Javad Mahmoudi-Gharaei; Akbar Fotouhi; Seyyed Ali Mozaffarpur; Mehdi Yaseri; Mostafa Hoseini
Journal:  BMC Med Res Methodol       Date:  2020-03-11       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.